[Correspondence] Drug-coated balloon angioplasty and stenting for coronary artery lesions

The conclusion in the REC-CAGEFREE-I trial by Chao Gao and colleagues1 that drug-coated balloon (DCB) angioplasty is inferior to drug-eluting stent (DES) deployment in patients with non-complex, de novo coronary artery disease is such a sweeping statement that the linked Comment by Margaret B McEntegart and Ajay J Kirtane2 attempted to rebalance it.